Thompson JS - Search Results

1

T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejection.

Waid TH, Thompson JS, Siemionow M, Brown SA. Waid TH, et al. Among authors: thompson js. Drug Des Devel Ther. 2009 Sep 21;3:205-12. doi: 10.2147/dddt.s2750. Drug Des Devel Ther. 2009. PMID: 19920935 Free PMC article.

2

T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action.

Brown SA, Lucas BA, Waid TH, McKeown JW, Barve S, Jackson LR, Thompson JS. Brown SA, et al. Among authors: thompson js. Clin Transplant. 1996 Dec;10(6 Pt 2):607-13. Clin Transplant. 1996. PMID: 8996751

3

Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial.

Waid TH, Lucas BA, Thompson JS, McKeown JW, Brown S, Kryscio R, Skeeters LJ. Waid TH, et al. Among authors: thompson js. Transplantation. 1997 Jul 27;64(2):274-81. doi: 10.1097/00007890-199707270-00017. Transplantation. 1997. PMID: 9256187 Clinical Trial.

4

Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.

Waid TH, Thompson JS, McKeown JW, Brown SA, Sekela ME. Waid TH, et al. Among authors: thompson js. J Heart Lung Transplant. 1997 Sep;16(9):913-6. J Heart Lung Transplant. 1997. PMID: 9322140 Clinical Trial.

5

Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients.

Waid TH, Lucas BA, Thompson JS, Brown SA, Munch L, Prebeck RJ, Jezek D. Waid TH, et al. Among authors: thompson js. Transplantation. 1992 Jan;53(1):80-6. doi: 10.1097/00007890-199201000-00015. Transplantation. 1992. PMID: 1531095 Clinical Trial.

6

Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial.

Waid TH, Lucas BA, Thompson JS, Munch LC, Brown S, Kryscio R, Prebeck R, VanHoy MA, Jezek D. Waid TH, et al. Among authors: thompson js. Transplant Proc. 1991 Feb;23(1 Pt 2):1062-5. Transplant Proc. 1991. PMID: 1899152 Clinical Trial. No abstract available.

7

T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.

Waid TH, Lucas BA, Amlot P, Janossy G, Yacoub M, Cammisuli S, Jezek D, Rhoades J, Brown S, Thompson JS. Waid TH, et al. Among authors: thompson js. Am J Kidney Dis. 1989 Nov;14(5 Suppl 2):61-70. Am J Kidney Dis. 1989. PMID: 2479265

8

Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody.

Waid TH, Lucas BA, Thompson JS, Brown S, Moore D, Amlot P, Janossy G. Waid TH, et al. Among authors: thompson js. Transplant Proc. 1989 Feb;21(1 Pt 2):1778-84. Transplant Proc. 1989. PMID: 2652582 Clinical Trial. No abstract available.

9

Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients.

Thompson JS, Pomeroy C, Kryscio RJ, Brown SA, Reece D, Kramer R, Howard DS, VanZant G, Humphries S, Phillips G. Thompson JS, et al. Biol Blood Marrow Transplant. 2004 Dec;10(12):858-66. doi: 10.1016/j.bbmt.2004.09.006. Biol Blood Marrow Transplant. 2004. PMID: 15570254 Free article.

10

Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.

Lucas BA, Waid TH, Thompson JS, Brown SA, Munch LC, McKeown JW, Kryscio RJ, Prebeck RJ. Lucas BA, et al. Among authors: thompson js. Transplant Proc. 1993 Feb;25(1 Pt 1):543-5. Transplant Proc. 1993. PMID: 8438406 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

730 results

Search Page

Filters